Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers ...

President Donald Trump created a potentially existential crisis for Tylenol maker Kenvue Inc. with just three words about the ...

Shares of Kenvue Inc. slid 4.09% to $16.17 Thursday, on what proved to be an all-around rough trading session for the stock ...

Kenvue shares rose 6% in premarket trading on Tuesday, set to rebound from a record low hit in the previous session as U.S.

Earlier this week, the Trump administration publicly warned of a possible link between prenatal Tylenol use and autism, ...

Shares may be rising because investors expected the White House to announce stricter regulations on the medication, Citi ...

The White House is reportedly planning to link Tylenol use during pregnancy to autism. The news pushed Kenvue stock down 8%.

Economists saw “limited” risk to the pharmaceutical firm’s stock, despite some expected impact on Tylenol consumption.

Kenvue stock pares losses after Trump claims about Tylenol's link to autism. Citi analysts said there was a lack of new ...

President Donald Trump is set to speak today on how Tylenol may be linked to autism. Here's when, who makes Tylenol, and ...

Shares of consumer healthcare firm Kevnue dropped to a record low during regular trading Monday, then made up some ground ...

Analysts saw no new scientific evidence from the White House to support President Donald Trump linking Tylenol to autism.